Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00157664
Status:
UNKNOWN
Last Update Posted:
2008-06-17
First Post:
2005-09-07
Brief Title:
Long Study - Longitudinal Thrombosis in End Stage Renal Disease
Sponsor:
Hamilton Health Sciences Corporation
Organization:
McMaster University
Study Overview
Official Title:
Canadian Longitudinal Thrombosis in End Stage Renal Disease Pilot Study
Status:
UNKNOWN
Status Verified Date:
2008-06
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary focus of this study is to collect information through diagnostic testing blood sample analysis and patient data collection on patients starting hemodialysis to determine risk and preventative factors of bleeding and clotting events
Detailed Description:
Hemodialysis patients have a very high rate of heart attacks strokes and amputation These problems are caused by a blood vessel problem called atherosclerosis hardening of the arteries and by clotting Clotting is also a problem in the access which is their lifeline for hemodialysis We have early results which show that some risk factors for clotting in the general population are common in dialysis patients Bleeding is another significant problem within this population In this pilot study we will measure bleedingclotting factors in the blood of consenting patients who are just starting dialysis We will also do special tests to show how much calcium build up and atherosclerotic build up has happened in the arteries and whether the arteries are becoming stiff We will then follow patients for up to four years and record any health problems that might reflect bleeding clotting or a blood vessel problem At the end of the study we will compare people who have had bleeding clotting or blood vessel problem with those who have not and learn which of the measurements predicted problems We will go on to study potential treatments such as anti-clotting drugs which might prevent or delay the occurrence of such problems This would improve the health of dialysis patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None